Redmile Group, LLC

10% owner at RayzeBio, Inc. · on record since Sep 21, 2023
Former 10% Owner and Director at Science 37 Holdings, Inc. · on record since Mar 13, 2024
Director at Atara Biotherapeutics, Inc. · on record since May 23, 2025
10% owner at Verve Therapeutics, Inc. · on record since Jun 23, 2021
Director at FATE THERAPEUTICS INC · on record since Apr 22, 2026
10% owner at FATE THERAPEUTICS INC · on record since Apr 22, 2026
10% owner at ARRAY BIOPHARMA INC · on record since Aug 28, 2015
10% owner at Attovia Therapeutics, Inc. · on record since Aug 4, 2026
10% owner at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016
10% owner at AMICUS THERAPEUTICS, INC. · on record since Jun 13, 2016
10% owner at XERIS PHARMACEUTICALS INC · on record since Jun 27, 2018
Director at ALDER BIOPHARMACEUTICALS INC · on record since Apr 26, 2018
10% owner at Gritstone bio, Inc. · on record since Sep 27, 2018
10% owner at Replimune Group, Inc. · on record since Jul 25, 2018
10% owner at Allakos Inc. · on record since Jul 24, 2018
10% owner at VAPOTHERM INC · on record since Nov 16, 2018
10% owner at TCR2 THERAPEUTICS INC. · on record since Feb 21, 2019
10% owner at Akero Therapeutics, Inc. · on record since Jun 24, 2019
10% owner at · on record since Jun 24, 2019
10% owner at · on record since Jun 24, 2019
Director at · on record since Sep 23, 2019
10% owner at · on record since Sep 23, 2019
10% owner at · on record since Oct 29, 2019
10% owner at · on record since Oct 8, 2019
10% owner at · on record since Feb 11, 2020
10% owner at · on record since Jun 25, 2020
10% owner at · on record since Jun 9, 2020
10% owner at · on record since Apr 6, 2020
10% owner at · on record since Jul 30, 2020
10% owner at · on record since Jul 30, 2020
10% owner at · on record since Jul 30, 2020
10% owner at · on record since Aug 25, 2020
Director at · on record since Dec 28, 2020
Director at · on record since Nov 27, 2020
10% owner at · on record since Nov 27, 2020
Director at · on record since Oct 7, 2020
10% owner at · on record since Oct 7, 2020
Director at · on record since Jul 28, 2021
10% owner at · on record since Jul 21, 2021
10% owner at · on record since Aug 12, 2021
10% owner at · on record since Oct 28, 2021
Director at · on record since Oct 18, 2021
10% owner at · on record since Oct 18, 2021
10% owner at · on record since Oct 18, 2022
10% owner at · on record since Apr 24, 2019
10% owner at · on record since Apr 2, 2026
10% owner at · on record since Dec 28, 2020

Insider trading activity of Redmile Group, LLC

Transactions on record: 169; since Aug 28, 2015

Open-market buys: 26; $208.6M

Open-market sells: 9; $23.2M

Companies traded: 27; last filing Aug 7, 2026

Figures computed from official regulatory filings — .

Companies where Redmile Group, LLC has traded

4 tx · $10.2M · Aug 7, 2026
5 tx · Jul 24, 2026
16 tx · $102.5M · Jun 15, 2026
32 tx · $185.2M · Apr 2, 2026
6 tx · Jul 16, 2025
30 tx · $89.1M · Jul 2, 2025
4 tx · $7M · Jun 18, 2024
8 tx · $30M · Jun 14, 2024
6 tx · $39.9M · Jun 21, 2023
2 tx · $306.6K · Oct 18, 2022
1 tx · $125K · May 25, 2022
3 tx · $20M · Nov 4, 2021
3 tx · $25M · Aug 12, 2021
3 tx · $20M · Jun 23, 2021

Track record of Redmile Group, LLC

Statistical track record

Free account

Open-market buys: 51

Last buy: Aug 6, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Redmile Group, LLC

Co-insiders of Redmile Group, LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Attovia Therapeutics, Inc.Listing unverified	Aug 7, 2026	Other	782,854	—	n/a (No price was disclosed in the filing)		SEC
Attovia Therapeutics, Inc.Listing unverified	Aug 7, 2026	Buy	400,000	17.00 USD	$6.8M	conv 52ClusterFirst in 12mo	SEC
Attovia Therapeutics, Inc.Listing unverified	Aug 7, 2026	OtherD (derivative)	-782,854	—	n/a (No price was disclosed in the filing)		SEC
Attovia Therapeutics, Inc.Listing unverified	Aug 7, 2026	Buy	200,000	17.00 USD	$3.4M	conv 46ClusterFirst in 12mo	SEC
Atara Biotherapeutics, Inc.Listing on record	Jul 24, 2026	Exercise	195,211	—	n/a (No price was disclosed in the filing)		SEC
Atara Biotherapeutics, Inc.Listing on record	Jul 24, 2026	ExerciseD (derivative)	-38,735	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atara Biotherapeutics, Inc.Listing on record	Jul 24, 2026	Other	-60	—	n/a (No price was disclosed in the filing)		SEC
Atara Biotherapeutics, Inc.Listing on record	Jul 24, 2026	ExerciseD (derivative)	-101,089	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atara Biotherapeutics, Inc.Listing on record	Jul 24, 2026	ExerciseD (derivative)	-55,387	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
FATE THERAPEUTICS INCListing on record	Jun 15, 2026	AwardD (derivative)	87,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
FATE THERAPEUTICS INCListing on record	Apr 23, 2026	OtherD (derivative)	-266,280	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
FATE THERAPEUTICS INCListing on record	Apr 23, 2026	OtherD (derivative)	266,280	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADC Therapeutics SAListing unverified	Apr 2, 2026	Sell	-196,229	3.75 USD	$736.3K		SEC
ADC Therapeutics SAListing unverified	Apr 2, 2026	Sell	-169,265	3.80 USD	$643K		SEC
ADC Therapeutics SAListing unverified	Apr 2, 2026	Sell	-188,407	3.75 USD	$706.9K		SEC
ADC Therapeutics SAListing unverified	Apr 2, 2026	Sell	-2,634,506	3.28 USD	$8.6M	Unusual size	SEC
ADC Therapeutics SAListing unverified	Apr 2, 2026	Sell	-2,529,491	3.28 USD	$8.3M	Unusual size	SEC
ADC Therapeutics SAListing unverified	Apr 2, 2026	Sell	-162,517	3.80 USD	$617.4K		SEC
Shattuck Labs, Inc.Listing on record	Jul 16, 2025	AwardD (derivative)	33,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IGM Biosciences, Inc.Listing unverified	Jul 2, 2025	Award	828	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADC Therapeutics SAListing unverified	Jun 13, 2025	BuyD (derivative)	12,465,234	3.43 USD	$42.8M	Unusual sizeFirst in 12mo	SEC
ADC Therapeutics SAListing unverified	Jun 13, 2025	BuyD (derivative)	15,734,267	3.43 USD	$54M	Unusual sizeFirst in 12mo	SEC
FATE THERAPEUTICS INCListing on record	May 30, 2025	AwardD (derivative)	55,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IGM Biosciences, Inc.Listing unverified	Apr 2, 2025	Award	828	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IGM Biosciences, Inc.Listing unverified	Jan 2, 2025	Award	1,734	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Attovia Therapeutics, Inc.Listing unverified	Aug 7, 2026	Other	782,854	—	n/a (No price was disclosed in the filing)		SEC
Attovia Therapeutics, Inc.Listing unverified	Aug 7, 2026	Buy	400,000	17.00 USD	$6.8M	conv 52ClusterFirst in 12mo	SEC
Attovia Therapeutics, Inc.Listing unverified	Aug 7, 2026	OtherD (derivative)	-782,854	—	n/a (No price was disclosed in the filing)		SEC
Attovia Therapeutics, Inc.Listing unverified	Aug 7, 2026	Buy	200,000	17.00 USD	$3.4M	conv 46ClusterFirst in 12mo	SEC
Atara Biotherapeutics, Inc.Listing on record	Jul 24, 2026	Exercise	195,211	—	n/a (No price was disclosed in the filing)		SEC
Atara Biotherapeutics, Inc.Listing on record	Jul 24, 2026	ExerciseD (derivative)	-38,735	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atara Biotherapeutics, Inc.Listing on record	Jul 24, 2026	Other	-60	—	n/a (No price was disclosed in the filing)		SEC
Atara Biotherapeutics, Inc.Listing on record	Jul 24, 2026	ExerciseD (derivative)	-101,089	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atara Biotherapeutics, Inc.Listing on record	Jul 24, 2026	ExerciseD (derivative)	-55,387	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
FATE THERAPEUTICS INCListing on record	Jun 15, 2026	AwardD (derivative)	87,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
FATE THERAPEUTICS INCListing on record	Apr 23, 2026	OtherD (derivative)	-266,280	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
FATE THERAPEUTICS INCListing on record	Apr 23, 2026	OtherD (derivative)	266,280	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADC Therapeutics SAListing unverified	Apr 2, 2026	Sell	-196,229	3.75 USD	$736.3K		SEC
ADC Therapeutics SAListing unverified	Apr 2, 2026	Sell	-169,265	3.80 USD	$643K		SEC
ADC Therapeutics SAListing unverified	Apr 2, 2026	Sell	-188,407	3.75 USD	$706.9K		SEC
ADC Therapeutics SAListing unverified	Apr 2, 2026	Sell	-2,634,506	3.28 USD	$8.6M	Unusual size	SEC
ADC Therapeutics SAListing unverified	Apr 2, 2026	Sell	-2,529,491	3.28 USD	$8.3M	Unusual size	SEC
ADC Therapeutics SAListing unverified	Apr 2, 2026	Sell	-162,517	3.80 USD	$617.4K		SEC
Shattuck Labs, Inc.Listing on record	Jul 16, 2025	AwardD (derivative)	33,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IGM Biosciences, Inc.Listing unverified	Jul 2, 2025	Award	828	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADC Therapeutics SAListing unverified	Jun 13, 2025	BuyD (derivative)	12,465,234	3.43 USD	$42.8M	Unusual sizeFirst in 12mo	SEC
ADC Therapeutics SAListing unverified	Jun 13, 2025	BuyD (derivative)	15,734,267	3.43 USD	$54M	Unusual sizeFirst in 12mo	SEC
FATE THERAPEUTICS INCListing on record	May 30, 2025	AwardD (derivative)	55,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IGM Biosciences, Inc.Listing unverified	Apr 2, 2025	Award	828	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IGM Biosciences, Inc.Listing unverified	Jan 2, 2025	Award	1,734	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC